Invest Securities initiates ALGBE stock research coverage with a buy recommendation

Invest Securities initiates coverage of Global Bioenergies’ stock (Alternext Paris: ALGBE) with a €50.6 objective.

Invest Securities, a French Investment Bank, has specialized in small- and mid-cap and already covers over 100 stocks in sectors including IT, biotechnologies and renewables.

Following Gilbert Dupont, Edison Investment Research, ODDO Securities and Baader Bank, Invest Securities brings to five the number of financial analysts that cover the ALGBE stock.

François-Henri Sahakian, CFO of Global Bioenergies comments: “In two months the numbers of analysts covering Global Bioenergies increased from three to five. This growing interest for Global Bioenergies is the consequence of the recent reaching of key milestones (delivery of a first renewable gasoline batch, joint venture with Cristal Union to carry a first plant project). Coverage of the ALGBE stock by Invest Securities’ will give increased visibility to Global Bioenergies in the European market”.



Global Bioenergies is one of the few companies worldwide, and the only one in Europe, that is developing a process to convert renewable resources into hydrocarbons through fermentation. The Company initially focused its efforts on the production of isobutene, one of the most important petrochemical building blocks that can be converted into fuels, plastics, organic glass and elastomers. Global Bioenergies continues to improve the performances of its process, operates its industrial pilot, has begun the construction of its demo plant in Germany, and prepares the first full-scale plant through a Joint-Venture with Cristal Union, named IBN-One The company also replicated its achievement to propylene and butadiene, two members of the gaseous olefins family, key molecules at the heart of petrochemical industry. Global Bioenergies is listed on Alternext, Euronext Paris (FR0011052257 – ALGBE).


Should you like to be kept informed, subscribe to our news feed on
Follow us on Twitter: @GlobalBioenergi


François-Henri Sahakian
Chief Financial Officer
Tel : + 33 (0) 1 64 98 20 50
Email :

Download the PDF